4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-031200
Director bought 500 shares at $19.12 ($9,560)
From the SEC's structured data for this filing
Trades in this filing
Powell Andrew Kenneth William · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-16 | Purchase : show line 1 in the form | +500 | $19.12 | $9,560 | 500 | D |
| Open-market purchases · 500 sh · avg $19.12 · $9,560 | ||||||
Loading xslF345X03/doc4.xml…